Bionure, a CataloniaBio & HealthTech member, has set up a crowdfunding campaign on the Capital Cell platform to prepare performance tests with patients (Phase II of the clinical trials) of drug BN201 for multiple sclerosis.

On 22 May, at the Barcelona Science Park (Sala Dolors Aleu), the company will be holding an informative Meet the team session with its CEO, Dr Laurent Nguyen, and its medical director, Dr Lucía Septién-Vélez. They will be joined by Vicens Oliver, president of the GAEM Foundation.

The session is aimed at small investors who are interested.

More information